-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Intraductal papilloma of the breast: Short-review
Shinya Tajima, Ichiro Maeda, Keiko Kishimoto, Saeko Naruki, Akira Endo, Masatomo Doi, Motohiro Chosokabe, Koichiro Tsugawa, Masayuki Takagi, Junki Koike
Mini Review: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Estimating site costs prior to conducting clinical trials
Dorothee Arenz, Barbara Hero, Barbara F Eichhorst, Martin Langer, Lars Pester, Julia von Tresckow, Jrg J Vehreschild, Maria JGT Vehreschild, Oliver A Cornely
Special Report: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Is there a future for FabI inhibitors as antibacterial agents?
AW Karchmer, B Hafkin
Editorial: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Challenges in incentivizing the pharmaceutical industry to supporting pediatric oncology clinical trials
Paola Angelini, Kathryn Pritchard-Jones & Darren R Hargrave
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Personalized medicine in non-smallcell lung cancer: has it come of age?
Martin Sebastian, Martin Reck
Editorial: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation
-
Current evidence for the treatment of invasive fungal infections in immunocompromised patients
Jutta Auberger, Cornelia Lass-Flori
Review Article: Clinical Investigation